Streetbeat News

Partnerships

MYGN

Myriad Genetics partners with Ultima Genomics to explore the UG 100 sequencing platform, aiming to enhance clinical test offerings in oncology and reproductive genomics. The collaboration focuses on improving Myriad's Precise MRD test and launching the FirstGene Multiple Prenatal Screen.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 1:01 pm

MSFT

RZLV

Rezolve AI shares are trading higher following the announcement of a partnership with Microsoft to enhance global retail innovations using AI-powered commerce solutions.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:50 pm

LPTH

LightPath Technologies has received $0.5 million in Phase 2 funding from the U.S. Defense Department to qualify additional BlackDiamond glasses as substitutes for germanium. This follows a successful Phase 1 where three materials were qualified. Phase 2 will cover six more materials advancing to MRL-9 for defense applications.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:45 pm

UGRO

urban-gro has signed approximately $12 million in contracts within the cannabis sector, indicating a significant business development for the company.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:36 pm

IPW

iPower Inc. (NASDAQ:IPW) has partnered with Zyla by Ant International to enable Zyla's clients to expand sales on U.S. online marketplaces via iPower's SuperSuite platform. This partnership marks iPower's first step towards integrating supply chain financial services, enhancing its platform's value.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:36 pm

ICCT

iCoreConnect Inc. (NASDAQ:ICCT) has acquired the assets of the Healthcare Circle of Excellence, enhancing its position in the healthcare sector. This strategic acquisition aims to provide comprehensive solutions to healthcare practices, fostering independence and financial success.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:35 pm

TEVA

Teva Pharmaceuticals and mAbxience have expanded their strategic partnership to include a new oncology biosimilar candidate. This collaboration supports Teva's growth strategy and aims to provide affordable, high-quality treatments globally.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:34 pm

BKSY

BlackSky has secured a five-year, $290 million contract with the National Geospatial-Intelligence Agency (NGA) to provide real-time, AI-driven monitoring services. This contract highlights the demand for BlackSky's capabilities in monitoring global economic and military activities.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:33 pm

TCBP

TC BioPharm Limited is collaborating with Carnegie Mellon University to develop an AI solution for optimizing donor screening and matching in cell therapy. This initiative aims to improve manufacturing yields, production processes, and patient outcomes.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:33 pm

LPTH

LightPath Technologies has received Phase 2 funding from the U.S. Defense Department to further qualify its BlackDiamond material as a substitute for Germanium. This follows a successful Phase 1 qualification and aims to advance strategic defense material solutions.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:33 pm